Invokana Lawsuit Information
Diabetes drug manufacturer Johnson & Johnson, produced the drug Invokana since it has been linked to increased risks of kidney failure, myocardial infarction (heart attacks), other cardiovascular issues and ketoacidosis, which is characterized by dangerously high blood acid levels. Attorneys allege that the drug maker failed to warn patients and medical care providers of the risks associated with Invokana.
Invokana, contains the active ingredient canagliflozin, is in a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. Other SGLT2 inhibitors include dapagliflozin and empagliflozin. These drugs are marketed under various trade names in addition to Invokana and are manufactured by drug makers Janssen, AstraZeneca and Boehringer Ingelheim.
If you or a loved were prescribed Invokana or another SGLT2 inhibitor and developed ketoacidosis, kidney failure or cardiovascular issues, contact the drugrelatedlawsuits today for a free case evaluation. We can answer your questions in a free and confidential consultation. If you choose to pursue a claim for injuries, we will connect you with an affiliated Invokana attorney who can assist you with the legal process. The time to pursue a claim is limited, so contact us today.